Genetics and Genetic Testing in Pancreatic Cancer

Gastroenterology

Volumn 149, Issue 5, 2015, Pages 1252-1264.e4

  Whitcomb, David C ^a,b   Shelton, Celeste A ^a   Brand, Randall E ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Familial Pancreatic Cancer; Genetic Testing; Hereditary Breast and Ovarian Cancer Syndrome; Hereditary Pancreatitis

Indexed keywords

ADIPONECTIN; ATM PROTEIN; B RAF KINASE; BRCA1 PROTEIN; BRCA2 PROTEIN; CHLORINATED HYDROCARBON; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CYTOCHROME P450 1A2; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MANGANESE SUPEROXIDE DISMUTASE; MISMATCH REPAIR PROTEIN PMS2; POLYCYCLIC AROMATIC HYDROCARBON; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; PROTEIN P53; TRYPSINOGEN; TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CYSTIC FIBROSIS; DNA DAMAGE; DNA REPAIR; EARLY DIAGNOSIS; FAMILIAL ATYPICAL MULTIPLE MOLE MELANOMA SYNDROME; FAMILIAL CANCER; FAMILIAL COLON POLYPOSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENOTYPE ENVIRONMENT INTERACTION; GERMLINE MUTATION; HEREDITARY BREAST AND OVARIAN CANCER SYNDROME; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; OBESITY; PANCREAS ADENOCARCINOMA; PANCREAS CELL; PANCREATITIS; PEUTZ JEGHERS SYNDROME; PRIORITY JOURNAL; SOMATIC MUTATION; ENVIRONMENT; GENETIC PREDISPOSITION; GENETICS; INFLAMMATION; METABOLISM; MUTATION; PANCREAS CARCINOMA; PROCEDURES; RISK FACTOR;

BIOMARKERS, TUMOR; CARCINOMA, PANCREATIC DUCTAL; DNA REPAIR; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GERM-LINE MUTATION; HUMANS; INFLAMMATION; MUTATION; RISK FACTORS;

EID: 84943238840     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.07.057     Document Type: Article

References (154)

1. T.P. Yeo Demographics, epidemiology, and inheritance of pancreatic ductal adenocarcinoma Semin Oncol 42 2015 8 18
2. D.K. Andersen, A. Andren-Sandberg, E.J. Duell, and et al. Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop Pancreas 42 2013 1227 1237
3. S. Solomon, S. Das, R. Brand, and et al. Inherited pancreatic cancer syndromes Cancer J 18 2012 485 491
4. R.E. Brand, and H.T. Lynch Hereditary pancreatic adenocarcinoma. A clinical perspective Med Clin North Am 84 2000 665 675
5. J. Permuth-Wey, and K.M. Egan Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis Fam Cancer 8 2009 109 117
6. S. Yachida, S. Jones, I. Bozic, and et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer Nature 467 7319 2010 1114 1117
7. S. Yachida, and C.A. Iacobuzio-Donahue Evolution and dynamics of pancreatic cancer progression Oncogene 32 2013 5253 5260
8. N.M. Lindor, and M.H. Greene The concise handbook of family cancer syndromes. Mayo Familial Cancer Program J Natl Cancer Inst 90 1998 1039 1071
9. F.J. Couch, M.R. Johnson, K.G. Rabe, and et al. The prevalence of BRCA2 mutations in familial pancreatic cancer Cancer Epidemiol Biomarkers Prev 16 2007 342 346
10. Ferlay J, Soerjomataram I, Ervik M, et al. Cancer incidence and mortality worldwide: IARC CancerBase No. 11 Lyon, France: International Agency for Research on Cancer (IARC); 2014 [cited 2015 June 12]. Available at: http://globocan.iarc.fr. Accessed June 12, 2015.
11. S. Iodice, S. Gandini, P. Maisonneuve, and et al. Tobacco and the risk of pancreatic cancer: a review and meta-analysis Langenbecks Arch Surg 393 2008 535 545
12. E. Lucenteforte, C. La Vecchia, D. Silverman, and et al. Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4) Ann Oncol 23 2012 374 382
13. G. Andreotti, and D.T. Silverman Occupational risk factors and pancreatic cancer: a review of recent findings Mol Carcinog 51 1 2012 98 108
14. H.A. Risch Pancreatic cancer: Helicobacter pylori colonization, N-nitrosamine exposures, and ABO blood group Mol Carcinog 51 2012 109 118
15. D.C. Whitcomb, M.C. Gorry, R.A. Preston, and et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene Nat Genet 14 1996 141 145
16. M.C. Gorry, D. Gabbaizedeh, W. Furey, and et al. Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis Gastroenterology 113 1997 1063 1068
17. A. Lowenfels, P. Maisonneuve, E. DiMagno, and et al. Hereditary pancreatitis and the risk of pancreatic cancer J Natl Cancer Inst 89 1997 442 446
18. N. Howes, M.M. Lerch, W. Greenhalf, and et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe Clin Gastroenterol Hepatol 2 2004 252 261
19. V. Rebours, M.C. Boutron-Ruault, V. Jooste, and et al. Mortality rate and risk factors in patients with hereditary pancreatitis: uni- and multidimensional analyses Am J Gastroenterol 104 2009 2312 2317
20. A.B. Lowenfels, P. Maisonneuve, D.C. Whitcomb, and et al. Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis JAMA 286 2001 169 170
21. S. Raimondi, A.B. Lowenfels, A.M. Morselli-Labate, and et al. Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection Best Pract Res Clin Gastroenterol 24 2010 349 358
22. J.G. Hengstler, A. Bauer, H.K. Wolf, and et al. Mutation analysis of the cationic trypsinogen gene in patients with pancreatic cancer Anticancer Res 20 2000 2967 2974
23. J.B. Greer, and D.C. Whitcomb Inflammation and pancreatic cancer: an evidence-based review Curr Opin Pharmacol 9 2009 411 418
24. V. Rebours, P. Levy, J.F. Mosnier, and et al. Pathology analysis reveals that dysplastic pancreatic ductal lesions are frequent in patients with hereditary pancreatitis Clin Gastroenterol Hepatol 8 2010 206 212
25. A.B. Lowenfels, P. Maisonneuve, G. Cavallini, and et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group N Engl J Med 328 1993 1433 1437
26. S.T. Chari, V. Mohan, C.S. Pitchumoni, and et al. Risk of pancratic carcinoma in tropical calcifying pancreatitits: an epidemicologic study Pancreas 9 1994 62 66
27. J.P. Neglia, S.C. FitzSimmons, P. Maisonneuve, and et al. The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group N Engl J Med 332 1995 494 499
28. D. Yadav, and A.B. Lowenfels The epidemiology of pancreatitis and pancreatic cancer Gastroenterology 144 2013 1252 1261
29. E.J. Duell, E. Lucenteforte, S.H. Olson, and et al. Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4) Ann Oncol 23 2012 2964 2970
30. G.X. Tong, Q.Q. Geng, J. Chai, and et al. Association between pancreatitis and subsequent risk of pancreatic cancer: a systematic review of epidemiological studies Asian Pac J Cancer Prev 15 2014 5029 5034
31. J. Daniluk, Y. Liu, D. Deng, and et al. An NF-kappaB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice J Clin Invest 122 2012 1519 1528
32. M.P. di Magliano, and C.D. Logsdon Roles for KRAS in pancreatic tumor development and progression Gastroenterology 144 2013 1220 1229
33. M. Sarner, and P.B. Cotton Classification of pancreatitis Gut 25 1984 756 759
34. B. Philip, C.L. Roland, J. Daniluk, and et al. A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice Gastroenterology 145 2013 1449 1458
35. P. Bansal, and A. Sonnenberg Pancreatitis is a risk factor for pancreatic cancer Gastroenterology 109 1995 247 251
36. E. Fernandez, C. La Vecchia, M. Porta, and et al. Pancreatitis and the risk of pancreatic cancer Pancreas 11 1995 185 189
37. V. Balakrishnan, A.G. Unnikrishnan, V. Thomas, and et al. Chronic pancreatitis. A prospective nationwide study of 1,086 subjects from India JOP 9 2008 593 600
38. National Cancer Institute. SEER Stat fact sheets: pancreas cancer. Published 2015 [cited June 28, 2015]. Available from: http://seer.cancer.gov/statfacts/html/pancreas.html. Accessed June 28, 2015.
39. R.H. Hruban, N.V. Adsay, J. Albores-Saavedra, and et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions Am J Surg Pathol 25 2001 579 586
40. A. Maitra, and R.H. Hruban Pancreatic cancer Annu Rev Pathol 3 2008 157 188
41. N. Habbe, G. Shi, R.A. Meguid, and et al. Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice Proc Natl Acad Sci U S A 105 2008 18913 18918
42. S. Jones, X. Zhang, D.W. Parsons, and et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses Science 321 5897 2008 1801 1806
43. N. Waddell, M. Pajic, A.M. Patch, and et al. Whole genomes redefine the mutational landscape of pancreatic cancer Nature 518 7540 2015 495 501
44. R.C. Grant, I. Selander, A.A. Connor, and et al. Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer Gastroenterology 148 2015 556 564
45. J. Humphris, D.K. Chang, and A.V. Biankin Inherited susceptibility to pancreatic cancer in the era of next-generation sequencing Gastroenterology 148 2015 496 498
46. A. Mafficini, E. Amato, M. Fassan, and et al. Reporting tumor molecular heterogeneity in histopathological diagnosis PLoS One 9 8 2014 e104979
47. O. Kiraly, G. Gong, W. Olipitz, and et al. Inflammation-induced cell proliferation potentiates DNA damage-induced mutations in vivo PLoS Genet 11 2015 e1004901
48. A.D. Rhim, E.T. Mirek, N.M. Aiello, and et al. EMT and dissemination precede pancreatic tumor formation Cell 148 2012 349 361
49. J. Ling, Y. Kang, R. Zhao, and et al. KrasG12D-induced IKK2/beta/NF-kappaB activation by IL-1alpha and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma Cancer Cell 21 2012 105 120
50. H. Huang, Y. Liu, J. Daniluk, and et al. Activation of nuclear factor-kappaB in acinar cells increases the severity of pancreatitis in mice Gastroenterology 144 2013 202 210
51. R.E. Brand, M.M. Lerch, W.S. Rubinstein, and et al. Advances in counselling and surveillance of patients at risk for pancreatic cancer Gut 56 2007 1460 1469
52. S. Syngal, R.E. Brand, J.M. Church, and et al. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes Am J Gastroenterol 110 2015 223 262 quiz 263
53. S. Chen, and G. Parmigiani Meta-analysis of BRCA1 and BRCA2 penetrance J Clin Oncol 25 2007 1329 1333
54. S.J. Boulton Cellular functions of the BRCA tumour-suppressor proteins Biochem Soc Trans 34 Pt 5 2006 633 645
55. M.S. Brose, T.R. Rebbeck, K.A. Calzone, and et al. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program J Natl Cancer Inst 94 2002 1365 1372
56. J. Iqbal, A. Ragone, J. Lubinski, and et al. The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers Br J Cancer 107 2012 2005 2009
57. D. Thompson, D.F. Easton Breast Cancer Linkage Consortium Cancer Incidence in BRCA1 mutation carriers J Natl Cancer Inst 94 2002 1358 Journal of the National Cancer Institute. 2002;94(18):1358-1365
58. Breast Cancer Linkage Consortium Cancer risks in BRCA2 mutation carriers J Natl Cancer Inst 91 1999 1310 1316
59. F.M. Giardiello, G.J. Offerhaus, D.H. Lee, and et al. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis Gut 34 1993 1394 1396
60. K.W. Jasperson, T.M. Tuohy, D.W. Neklason, and et al. Hereditary and familial colon cancer Gastroenterology 138 2010 2044 2058
61. A.K. Win, J.P. Young, N.M. Lindor, and et al. Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study J Clin Oncol 30 2012 958 964
62. F. Kastrinos, B. Mukherjee, N. Tayob, and et al. Risk of pancreatic cancer in families with Lynch syndrome JAMA 302 2009 1790 1795
63. F.M. Giardiello, J.D. Brensinger, A.C. Tersmette, and et al. Very high risk of cancer in familial Peutz-Jeghers syndrome Gastroenterology 119 2000 1447 1453
64. S. Syngal, R.E. Brand, J.M. Church, and et al. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes Am J Gastroenterol 110 2015 223 262
65. M.W. Ruijs, S. Verhoef, M.A. Rookus, and et al. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes J Med Genet 47 2010 421 428
66. P.H. Fernandes, J. Saam, J. Peterson, and et al. Comprehensive sequencing of PALB2 in patients with breast cancer suggests PALB2 mutations explain a subset of hereditary breast cancer Cancer 120 2014 963 967
67. A.C. Antoniou, S. Casadei, T. Heikkinen, and et al. Breast-cancer risk in families with mutations in PALB2 N Engl J Med 371 2014 497 506
68. B. Geoffroy-Perez, N. Janin, K. Ossian, and et al. Cancer risk in heterozygotes for ataxia-telangiectasia Int J Cancer 93 2001 288 293
69. N.J. Roberts, Y. Jiao, J. Yu, and et al. ATM mutations in patients with hereditary pancreatic cancer Cancer Discov 2 2012 41 46
70. K.L. Pogue-Geile, R. Chen, M.P. Bronner, and et al. Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism PLoS Med 3 2006 e516
71. C.A. Otey, A. Rachlin, M. Moza, and et al. The palladin/myotilin/myopalladin family of actin-associated scaffolds Int Rev Cytol 246 2005 31 58
72. E. Slater, V. Amrillaeva, V. Fendrich, and et al. Palladin mutation causes familial pancreatic cancer: absence in European families PLoS Med 4 2007 e164
73. A.P. Klein, M. Borges, M. Griffith, and et al. Absence of deleterious palladin mutations in patients with familial pancreatic cancer Cancer Epidemiol Biomarkers Prev 18 2009 1328 1330
74. R. Mounzer, and D.C. Whitcomb Genetics of acute and chronic pancreatitis Curr Opin Gastroenterol 29 2013 544 551
75. C.D. Ulrich II Pancreatic cancer in hereditary pancreatitis - consensus guidelines for prevention, screening, and treatment Pancreatology 1 2001 416 422
76. M.D. Bellin, M.L. Freeman, A. Gelrud, and et al. Total pancreatectomy and islet autotransplantation in chronic pancreatitis: recommendations from PancreasFest Pancreatology 14 2014 27 35
77. A. Schneider, J. Larusch, X. Sun, and et al. Combined bicarbonate conductance-impairing variants in CFTR and SPINK1 variants are associated with chronic pancreatitis in patients without cystic fibrosis Gastroenterology 140 2011 162 171
78. J. LaRusch, J. Jung, I.J. General, and et al. Mechanisms of CFTR functional variants that impair regulated bicarbonate permeation and increase risk for pancreatitis but not for cystic fibrosis PLoS Genet 10 2014 e1004376
79. J. LaRusch, J. Jung, I.J. General, and et al. Mechanisms of CFTR functional variants that impair regulated bicarbonate permeation and increase risk for pancreatitis but not for cystic fibrosis PLoS Genet 10 2014 e1004376
80. J. Rosendahl, O. Landt, J. Bernadova, and et al. CFTR, SPINK1, CTRC and PRSS1 variants in chronic pancreatitis: is the role of mutated CFTR overestimated? Gut 62 2013 582 592
81. P. Maisonneuve, B.C. Marshall, and A.B. Lowenfels Risk of pancreatic cancer in patients with cystic fibrosis Gut 56 2007 1327 1328
82. D.C. Whitcomb Genetic risk factors for pancreatic disorders Gastroenterology 144 2013 1292 1302
83. J.M. Chen, and C. Ferec Genetics and pathogenesis of chronic pancreatitis: the 2012 update Clin Res Hepatol Gastroenterol 36 2012 334 340
84. J.M. Chen, and C. Ferec Chronic pancreatitis: genetics and pathogenesis Annu Rev Genomics Hum Genet 10 2009 63 87
85. P. Felderbauer, P. Hoffmann, H. Einwachter, and et al. A novel mutation of the calcium sensing receptor gene is associated with chronic pancreatitis in a family with heterozygous SPINK1 mutations BMC Gastroenterol 3 2003 34
86. P. Felderbauer, E. Karakas, V. Fendrich, and et al. Pancreatitis in primary hyperparathyroidism-related hypercalcaemia is not associated with mutations in the CASR gene Exp Clin Endocrinol Diabetes 115 2007 527 529
87. V. Muddana, J. Lamb, J.B. Greer, and et al. Association between calcium sensing receptor gene polymorphisms and chronic pancreatitis in a US population: role of serine protease inhibitor Kazal 1type and alcohol World J Gastroenterol 14 2008 4486 4491
88. M. Zenker, J. Mayerle, M.M. Lerch, and et al. Deficiency of UBR1, a ubiquitin ligase of the N-end rule pathway, causes pancreatic dysfunction, malformations and mental retardation (Johanson-Blizzard syndrome) Nat Genet 37 2005 1345 1350
89. G.R. Boocock, J.A. Morrison, M. Popovic, and et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome Nat Genet 33 2003 97 101
90. H. Raeder, S. Johansson, P.I. Holm, and et al. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction Nat Genet 38 2006 54 62
91. D.C. Whitcomb, J. Larusch, A.M. Krasinskas, and et al. Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis Nat Genet 44 2012 1349 1354
92. H. Witt, S. Beer, J. Rosendahl, and et al. Variants in CPA1 are strongly associated with early onset chronic pancreatitis Nat Genet 45 2013 1216 1220
93. H. Brand, B. Diergaarde, M.R. O'Connell, and et al. Variation in the gamma-glutamyltransferase 1 gene and risk of chronic pancreatitis Pancreas 42 2013 836 840
94. C.A. Shelton, and D.C. Whitcomb Genetics and treatment options for recurrent acute and chronic pancreatitis Curr Treat Options Gastroenterol 12 2014 359 371
95. B. Diergaarde, R. Brand, J. Lamb, and et al. Pooling-based genome-wide association study implicates gamma-glutamyltransferase 1 (GGT1) gene in pancreatic carcinogenesis Pancreatology 10 2010 194 200
96. K.A. Brune, B. Lau, E. Palmisano, and et al. Importance of age of onset in pancreatic cancer kindreds J Natl Cancer Inst 102 2010 119 126
97. A.P. Klein, K.A. Brune, G.M. Petersen, and et al. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds Cancer Res 64 2004 2634 2638
98. R.E. Brand, J.B. Greer, E. Zolotarevsky, and et al. Pancreatic cancer patients who smoke and drink are diagnosed at younger ages Clin Gastroenterol 7 2009 1007 1012
99. M. Schenk, A.G. Schwartz, E. O'Neal, and et al. Familial risk of pancreatic cancer J Natl Cancer Inst 93 2001 640 644
100. H. Arem, K. Yu, X. Xiong, and et al. Vitamin D metabolic pathway genes and pancreatic cancer risk PLoS One 10 2015 e0117574
101. L. Wu, K.G. Rabe, and G.M. Petersen Do variants associated with susceptibility to pancreatic cancer and type 2 diabetes reciprocally affect risk? PLoS One 10 2015 e0117230
102. L. Wu, A.M. Goldstein, K. Yu, and et al. Variants associated with susceptibility to pancreatic cancer and melanoma do not reciprocally affect risk Cancer Epidemiol Biomarkers Prev 23 2014 1121 1124
103. L. Amundadottir, P. Kraft, R.Z. Stolzenberg-Solomon, and et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer Nat Genet 41 2009 986 990
104. J.B. Greer, M.H. Yazer, J.S. Raval, and et al. Significant association between ABO blood group and pancreatic cancer World J Gastroenterol 16 2010 5588 5591
105. B.M. Wolpin, P. Kraft, M. Gross, and et al. Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium Cancer Res 70 2010 1015 1023
106. H.A. Risch, L. Lu, J. Wang, and et al. ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis Am J Epidemiol 177 2013 1326 1337
107. M. Nakao, K. Matsuo, S. Hosono, S. Ogata, H. Ito, M. Watanabe, and et al. ABO blood group alleles and the risk of pancreatic cancer in a Japanese population Cancer Sci 102 2011 1076 1080
108. H.A. Risch, H. Yu, and et al. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study J Natl Cancer Inst 102 2010 502 505
109. F.U. Weiss, C. Schurmann, A. Guenther, and et al. Fucosyltransferase 2 (FUT2) non-secretor status and blood group B are associated with elevated serum lipase activity in asymptomatic subjects, and an increased risk for chronic pancreatitis: a genetic association study Gut 64 2015 646 656
110. E.J. Childs, E. Mocci, D. Campa, and et al. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer Nat Genet 47 2015 911 916
111. T.A. Manolio, F.S. Collins, N.J. Cox, and et al. Finding the missing heritability of complex diseases Nature 461 7265 2009 747 753
112. J. Larusch, M.M. Barmada, S. Solomon, and et al. Whole exome sequencing identifies multiple, complex etiologies in an idiopathic hereditary pancreatitis kindred JOP 13 2012 258 262
113. J. LaRusch, A. Lozano-Leon, K. Stello, and et al. The common chymotrypsinogen C (CTRC) variant G60G (C.180T) increases risk of chronic pancreatitis but not recurrent acute pancreatitis in a North American population Clin Transl Gastroenterol 6 2015 e68
114. D.C. Whitcomb What is personalized medicine and what should it replace? Nat Rev Gastroenterol Hepatol 9 2012 418 424
115. A.H. Beck STUDENTJAMA. The Flexner report and the standardization of American medical education JAMA 291 2004 2139 2140
116. A. Flexner Medical Education in the United States and Candida: A Report to the Carnegie Foundation for the Advancement of Teaching 1910 Carnegie Foundation for the Advancement of Teaching New York
117. R. Maeshiro, I. Johnson, D. Koo, and et al. Medical education for a healthier population: reflections on the Flexner Report from a public health perspective Acad Med 85 2010 211 219
118. H. Tang, P. Wei, E.J. Duell, and et al. Axonal guidance signaling pathway interacting with smoking in modifying the risk of pancreatic cancer: a gene- and pathway-based interaction analysis of GWAS data Carcinogenesis 35 2014 1039 1045
119. A.J.J. Atkinson, W.A. Colburn, V.G. DeGruttola, and et al. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework Clin Pharmacol Ther 69 2001 89 95
120. L. Jiao, M.M. Hassan, M.L. Bondy, and et al. XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer Am J Gastroenterol 103 2008 360 367
121. P.Y. Fong, M.D. Fesinmeyer, E. White, and et al. Association of diabetes susceptibility gene calpain-10 with pancreatic cancer among smokers J Gastrointest Cancer 41 2010 203 208
122. J.H. Jang, M. Cotterchio, A. Borgida, and et al. Genetic variants in carcinogen-metabolizing enzymes, cigarette smoking and pancreatic cancer risk Carcinogenesis 33 2012 818 827
123. M. Yang, T. Sun, Y. Zhou, and et al. The functional cytotoxic T lymphocyte-associated protein 4 49G-to-A genetic variant and risk of pancreatic cancer Cancer 118 2012 4681 4686
124. H. Suzuki, J.S. Morris, Y. Li, and et al. Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer Carcinogenesis 29 2008 1184 1191
125. L. Jiao, M.M. Hassan, M.L. Bondy, and et al. The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk Cancer Lett 245 1-2 2007 61 68
126. M. Nakao, S. Hosono, H. Ito, and et al. Interaction between IGF-1 polymorphisms and overweight for the risk of pancreatic cancer in Japanese Int J Mol Epidemiol Genet 2 2011 354 366
127. H. Tang, X. Dong, M. Hassan, and et al. Body mass index and obesity- and diabetes-associated genotypes and risk for pancreatic cancer Cancer Epidemiol Biomarkers Prev 20 2011 779 792
128. R.J. Jansen, D.P. Robinson, R.Z. Stolzenberg-Solomon, and et al. Polymorphisms in metabolism/antioxidant genes may mediate the effect of dietary intake on pancreatic cancer risk Pancreas 42 2013 1043 1053
129. H. Tang, X. Dong, R.S. Day, and et al. Antioxidant genes, diabetes and dietary antioxidants in association with risk of pancreatic cancer Carcinogenesis 31 2010 607 613
130. B. Mohelnikova-Duchonova, D. Vrana, I. Holcatova, and et al. CYP2A13, ADH1B, and ADH1C gene polymorphisms and pancreatic cancer risk Pancreas 39 2010 144 148
131. X. Dong, Y. Li, H. Tang, and et al. Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer Cancer Epidemiol 36 2012 206 211
132. R.J. Jansen, X.L. Tan, and G.M. Petersen Gene-by-environment interactions in pancreatic cancer: implications for prevention Yale J Biol Med 88 2015 115 126
133. A.M. Goldstein, M.C. Fraser, J.P. Struewing, and et al. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations N Engl J Med 333 1995 970 974
134. H.F. Vasen, N.A. Gruis, R.R. Frants, and et al. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden) Int J Cancer 87 2000 809 811
135. A. Borg, T. Sandberg, K. Nilsson, and et al. High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families J Natl Cancer Inst 92 2000 1260 1266
136. R.R. McWilliams, E.D. Wieben, K.G. Rabe, and et al. Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling Eur J Hum Genet 19 2011 472 478
137. P. Ghiorzo, G. Fornarini, S. Sciallero, and et al. CDKN2A is the main susceptibility gene in Italian pancreatic cancer families J Med Genet 49 2012 164 170
138. R. Schneider, E.P. Slater, M. Sina, and et al. German national case collection for familial pancreatic cancer (FaPaCa): ten years experience Fam Cancer 10 2011 323 330
139. Breast Cancer Linkage Consortium Cancer risks in BRCA2 mutation carriers J Natl Cancer Inst 91 1999 1310 1316
140. C.J. van Asperen, R.M. Brohet, E.J. Meijers-Heijboer, and et al. Cancer risks in BRCA2 families: estimates for sites other than breast and ovary J Med Genet 42 2005 711 719
141. S. Jones, R.H. Hruban, M. Kamiyama, and et al. Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene Science 324 5924 2009 217
142. L.C. Murtaugh Pathogenesis of pancreatic cancer: lessons from animal models Toxicol Pathol 42 2014 217 228
143. S.R. Hingorani, E.F. Petricoin, A. Maitra, and et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse Cancer Cell 4 2003 437 450
144. M. Wagner, F.R. Greten, C.K. Weber, and et al. A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease Genes Dev 15 2001 286 293
145. A.J. Aguirre, N. Bardeesy, M. Sinha, and et al. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma Genes Dev 17 2003 3112 3126
146. S.R. Hingorani, L. Wang, A.S. Multani, and et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice Cancer Cell 7 2005 469 483
147. P. Pour, J. Althoff, F.W. Kruger, and et al. A potent pancreatic carcinogen in Syrian hamsters: N-nitrosobis(2-oxopropyl)amine J Natl Cancer Inst 58 1977 1449 1453
148. P.J. Grippo, P.S. Nowlin, M.J. Demeure, and et al. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice Cancer Res 63 2003 2016 2019
149. M.A. Collins, F. Bednar, Y. Zhang, and et al. Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice J Clin Invest 122 2012 639 653
150. H. Ying, A.C. Kimmelman, C.A. Lyssiotis, and et al. Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism Cell 149 2012 656 670
151. K.L. Bryant, J.D. Mancias, A.C. Kimmelman, and et al. KRAS: feeding pancreatic cancer proliferation Trends Biochem Sci 39 2014 91 100
152. R. Kang, W. Hou, Q. Zhang, and et al. RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer Cell Death Dis 5 2014 e1480
153. O. Strobel, Y. Dor, J. Alsina, and et al. In vivo lineage tracing defines the role of acinar-to-wductal transdifferentiation in inflammatory ductal metaplasia Gastroenterology 133 2007 1999 2009
154. R.E. Stopczynski, D.P. Normolle, D.J. Hartman, and et al. Neuroplastic changes occur early in the development of pancreatic ductal adenocarcinoma Cancer Res 74 2014 1718 1727